"Legal highs" on the net-Evaluation of UK-based Websites, products and product information

Forensic Science International

Volumn 206, Issue 1-3, 2011, Pages 92-97

  Schmidt, Martin M ^a   Sharma, Akhilesh ^a   Schifano, Fabrizio ^b   Feinmann, Charlotte ^c  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Legal highs; Party pills; Substance misuse; UK

Indexed keywords

3 (1 NAPHTHOYL) 1 PENTYLINDOLE; 3 [2 HYDROXY 4 (1,1 DIMETHYLHEPTYL)PHENYL]CYCLOHEXANOL; CENTRAL STIMULANT AGENT; IBOTENIC ACID; ILLICIT DRUG; LYSERGAMIDE; MITRAGYNINE; MUSCIMOL; PLANT EXTRACT; PSYCHEDELIC AGENT; SALIVINORIN A; SEDATIVE AGENT; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL COMPOSITION; CONSUMER; DATA BASE; DRUG CONTRAINDICATION; DRUG INFORMATION; DRUG INTERACTION; DRUG MARKETING; INFORMATION; INTERNET; PILL; PRIORITY JOURNAL; PRODUCT SAFETY; SALVIA; SALVIA DIVINORUM; SIDE EFFECT; SMOKING; UNITED KINGDOM;

EID: 79551628856     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.forsciint.2010.06.030     Document Type: Article

References (44)

1. European Monitoring Centre for Drugs and Drug Abuse, Annual report 2008: the state of the drugs problem in Europe, Office for Official Publications of the European Communities, Luxembourg, 2008, pp. 90-92.
2. Spiritual High LTD, Benzylpiperazine Industry Advice to the Advisory Council on the Misuse of Drugs on: benzylpiperazine, Spiritual High LTD, 2006.
3. Dennehy C.E., Tsourounis C., Miller A.E. Evaluation of herbal dietary supplements marketed on the Internet for recreational use. Ann. Pharmacother. 2005, 39:1634-1639.
4. Russell B. Party pills-how little is known?. New Zealand Family Physician 2006, 33:46.
5. A. Topping, Legal dance drug faces ban amid fears over side-effects. The Guardian, June 18, 2007.
6. O. Bowcott, Move to ban stimulant BZP. The Guardian, March 4, 2008.
7. Auwarter V., Dresen S., Weinmann W., Muller M., Putz M., Ferreiros N. 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs?. J. Mass Spectromet. 2009, 44:832-837.
8. European Monitoring Centre for Drugs and Drug Abuse, Understanding the " Spice" phenomenon, Office for the Official Publications of the European Communities, Luxembourg, 2009.
9. Lindigkeit R., Boehme A., Eiserloh I., Luebbecke M., Wiggermann M., Ernst L., Beuerle T. Spice: a never ending story?. Forensic Sci. Int. 2009.
10. The Misuse of Drugs Act 1971 (Amendment) Order 2009, 2009.
11. Advisory Council on the Misuse of Drugs, Control of 1-benzylpiperazine (BZP) and related compounds, Home Office, London, 2008.
12. Advisory Council on the Misuse of Drugs, Consideration of the major cannabinoid agonists, Home Office, London, 2009.
13. European Monitoring Centre for Drugs and Drug Abuse, Report on the risk assessment of BZP in the framework of the Council decision on new psychoactive substances, Office for Official Publications of the European Communities, Luxembourg, 2009.
14. European Monitoring Centre for Drugs and Drug Abuse, Annual report 2009: the state of the drugs problem in Europe, Office for Official Publications of the European Communities, Luxembourg, 2009, pp. 91-94.
15. Austin H., Monasterio E. Acute psychosis following ingestion of 'Rapture'. Australasian Psychiatry 2004, 12:406-408.
16. Gee P., Gilbert M., Richardson S., Moore G., Paterson S., Graham P. Toxicity from the recreational use of 1-benzylpiperazine. Clin. Toxicol. 2008, 46:802-807.
17. Theron L., Jansen K., Miles J. Benzylpiperizine-based party pills' impact on the Auckland City Hospital Emergency Department Overdose Database (2002-2004) compared with ecstasy (MDMA or methylene dioxymethamphetamine), gamma hydroxybutyrate (GHB), amphetamines, cocaine, and alcohol.[see comment]. New Zealand Med. J. 2007, 120:U2416.
18. Olsen D.G., Bronstein A.C., Fisher J., Bartalini M. Green hornet: teenage agony and ecstasy. Clin. Toxicol. 2004, 42:765.
19. Nicholson T.C. Prevalence of use, epidemiology and toxicity of 'herbal party pills' among those presenting to the emergency department. Emergency Med. Australasia 2006, 18:180-184.
20. C. Wilkins, M. Girling, P. Sweetsur, T. Huckle, J. Huakau, Legal party pill use in New Zealand: Prevalence of use, availability, health harms and 'gateway effects' of benzylpiperazine (BZP) and trifluorophenylmethylpiperazine (TFMPP). Auckland: Centre for Social and Health Outcomes Research and Evaluation (SHORE), Massey University, 2006.
21. Transform, Piperazines-how to regulate an emerging recreational drug not covered by existing legislation, Transform, 2006.
22. D. McCandles, Exotic, legal highs become big business as 'headshops' boom. The Guardian, January 9, 2006.
23. T. Lamont, The rise and rise of legal highs. The Observer, October 11, 2008.
24. Doughty C., Walker A., Brenchley J. Herbal mind altering substances: an unknown quantity?. Emergency Med. J. 2004, 21:253-255.
25. Wood D.M., Dargan P.I., Button J., Holt D.W., Ovaska H., Ramsey J., Jones A.L. Collapse, reported seizure--and an unexpected pill. The Lancet 2007, 369:1411-1413.
26. D. Dick, C. Torrance, MixMag Drugs Survey, MixMag, Development Hell, London, 2010, pp. 44-53.
27. Schifano F., Leoni M., Martinotti G., Rawaf S., Rovetto F. Importance of cyberspace for the assessment of the drug abuse market: preliminary results from the Psychonaut 2002 project. Cyberpsychol. Behav. 2003, 6:405-410.
28. Schifano F., Deluca P., Baldacchino A., Peltoniemi T., Scherbaum N., Torrens M., Farre M., Flores I., Rossi M., Eastwood D., Guionnet C., Rawaf S., Agosti L., Di Furia L., Brigada R., Majava A., Siemann H., Leoni M., Tomasin A., Rovetto F., Ghodse A.H. Drugs on the web; the Psychonaut 2002EU project. Prog. Neuropsychopharmacol. Biol. Psychiatry 2006, 30:640-646.
29. Hillebrand J., Olszewski D., Sedefov R. Legal highs on the Internet. Subst Use Misuse 2010, 45:330-340.
30. Randomizer, Research Randomizer: Free Random Sampling and Random Assignment, Online, 2008.
31. Babu K.M., McCurdy C.R., Boyer E.W. Opioid receptors and legal highs: Salvia divinorum and Kratom. Clin. Toxicol. 2008, 46:146-152.
32. TICTAC Communications Ltd., TicTac for Healthcare, Online, 2009.
33. de Boer D., Egberts T., Maes R.A. Para-methylthioamphetamine, a new amphetamine designer drug of abuse. Pharm. World Sci. 1999, 21:47-48.
34. Medicines and Healthcare products Regulatory Agency, Press release: Benzylpiperazine (PEP) pills are dangerous and illegal, MHRA, 2007.
35. Vohra R., Seefeld A., Cantrell F.L., Clark R.F. Salvia divinorum: exposures reported to a statewide poison control system over 10 years. J. Emerg Med. 2009.
36. Bjornstad K., Hulten P., Beck O., Helander A. Bioanalytical and clinical evaluation of 103 suspected cases of intoxications with psychoactive plant materials. Clin. Toxicol. (Phila) 2009, 47:566-572.
37. Gopel C., Maras A., Schmidt M.H. [Hawaiian baby rose wood: case report of an argyreia nervosa induced toxic psychosis]. Psychiatr Prax 2003, 30:223-224.
38. Gertsch J.H., Wood C. Case report: an ingestion of Hawaiian Baby Woodrose seeds associated with acute psychosis. Hawaii Med. J. 2003, 62. 127, 129.
39. Satora L., Pach D., Butryn B., Hydzik P., Balicka-Slusarczyk B. Fly agaric (Amanita muscaria) poisoning, case report and review. Toxicon 2005, 45:941-943.
40. Brvar M., Mozina M., Bunc M. Prolonged psychosis after Amanita muscaria ingestion. Wien Klin Wochenschr 2006, 118:294-297.
41. Frison G., Favretto D., Zancanaro F., Fazzin G., Ferrara S.D. A case of beta-carboline alkaloid intoxication following ingestion of Peganum harmala seed extract. Forensic Sci. Int. 2008, 179:e37-43.
42. Alansari M., Hamilton D. Nephrotoxicity of BZP-based herbal party pills: a New Zealand case report. New Zealand Med. J. 2006, 119:U1959.
43. Dargan P.I., Button J., Hawkins L., Archer J.R.H., Ovaska H., Lidder S., Ramsey J., Holt D.W., Wood D.M. Detection of the pharmaceutical agent glaucine as a recreational drug. Eur. J. Clin. Pharmacol. 2008, 64:553-554.
44. Zimmermann U.S., Winkelmann P.R., Pilhatsch M., Nees J.A., Spanagel R., Schulz K. Withdrawal phenomena and dependence syndrome after the consumption of " Spice Gold" Deutsches Arzteblatt Int. 2009, 106:464-467.